DOES CONCOMITANT BENZODIAZEPINE USE REDUCE THE EFFICACY OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION FOR TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER

被引:0
|
作者
Tran, L. [1 ]
Clarke, P. [2 ,3 ]
Gill, S. [2 ,3 ]
Paterson, T. [2 ,3 ]
Hahn, L. [2 ]
Galletly, C. [2 ,3 ,4 ]
机构
[1] Univ Adelaide, Adelaide, SA, Australia
[2] Ramsay Hlth Care SA Mental Hlth Serv, Adelaide Clin, Adelaide, SA, Australia
[3] Univ Adelaide, Sch Med, Discipline Psychiat, Adelaide, SA, Australia
[4] Northern Adelaide Local Hlth Network, Adelaide, SA, Australia
来源
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2021年 / 55卷 / 1_SUPPL期
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:86 / 87
页数:2
相关论文
共 50 条
  • [1] Benzodiazepine use and response to repetitive transcranial magnetic stimulation in Major Depressive Disorder
    Fitzgerald, Paul B.
    Daskalakis, Zafiris J.
    Hoy, Kate E.
    BRAIN STIMULATION, 2020, 13 (03) : 694 - 695
  • [2] Rumination symptoms in treatment-resistant major depressive disorder, and outcomes of repetitive Transcranial Magnetic Stimulation (rTMS) treatment
    Stephanie A. Chu
    Reza Tadayonnejad
    Juliana Corlier
    Andrew C. Wilson
    Cole Citrenbaum
    Andrew F. Leuchter
    Translational Psychiatry, 13
  • [3] The role of repetitive transcranial magnetic stimulation in the treatment of mental disorders, especially in treatment-resistant major depressive disorder
    Pilisi Robert
    Tenyi Tamas
    Bueki Andras
    Kovacs Norbert
    Zemplenyi Antal
    Sebestyen Gabriella
    Osvath Peter
    Fekete Sandor
    Voeroes Viktor
    ORVOSI HETILAP, 2020, 161 (01) : 3 - 10
  • [4] Rumination symptoms in treatment-resistant major depressive disorder, and outcomes of repetitive Transcranial Magnetic Stimulation (rTMS) treatment
    Chu, Stephanie A.
    Tadayonnejad, Reza
    Corlier, Juliana
    Wilson, Andrew C.
    Citrenbaum, Cole
    Leuchter, Andrew F.
    TRANSLATIONAL PSYCHIATRY, 2023, 13 (01)
  • [5] Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder
    Hunter, Aimee M.
    Minzenberg, Michael J.
    Cook, Ian A.
    Krantz, David E.
    Levitt, Jennifer G.
    Rotstein, Natalie M.
    Chawla, Shweta A.
    Leuchter, Andrew F.
    BRAIN AND BEHAVIOR, 2019, 9 (05):
  • [6] Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation With a 2-Coil Device in Treatment-Resistant Major Depressive Disorder
    Kavanaugh, Brian C.
    Aaronson, Scott T.
    Clarke, Gregory N.
    Holtzheimer, Paul E.
    Johnson, Clark W.
    McDonald, William M.
    Schneider, M. Bret
    Carpenter, Linda L.
    JOURNAL OF ECT, 2018, 34 (04) : 258 - 265
  • [7] An Update on Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder
    Trevizol, Alisson P.
    Blumberger, Daniel M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (04) : 747 - 762
  • [8] Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: An open label trial
    McGirr, Alexander
    Van den Eynde, Frederique
    Tovar-Perdomo, Santiago
    Fleck, Marcelo P. A.
    Berlim, Marcelo T.
    JOURNAL OF AFFECTIVE DISORDERS, 2015, 173 : 216 - 220
  • [9] Repetitive Transcranial Magnetic Stimulation for Comorbid Major Depressive Disorder and Alcohol Use Disorder
    Tang, Victor M.
    Le Foll, Bernard
    Blumberger, Daniel M.
    Voineskos, Daphne
    BRAIN SCIENCES, 2022, 12 (01)
  • [10] Psychostimulant use and clinical outcome of repetitive transcranial magnetic stimulation treatment of major depressive disorder
    Wilke, Scott A.
    Johnson, Crystal L.
    Corlier, Juliana
    Marder, Katharine G.
    Wilson, Andrew C.
    Pleman, Christopher M.
    Leuchter, Andrew F.
    DEPRESSION AND ANXIETY, 2022, 39 (05) : 397 - 406